Literature DB >> 2999296

Effects of imidazole- and triazole-derivative antifungal compounds on the growth and morphological development of Candida albicans hyphae.

F C Odds, A Cockayne, J Hayward, A B Abbott.   

Abstract

Six azole-derivative antifungal compounds affected several aspects of Candida albicans hyphal development with only a relatively small degree of inhibition of growth rate, measured in terms of ATP concentration, whereas amphotericin B and 5-fluorocytosine affected morphology only when they also substantially inhibited fungal growth rate. At 10(-8) M, all the azoles tested inhibited branch formation by C. albicans hyphae. At 10(-7) M and higher concentrations, clotrimazole and miconazole strongly suppressed emergence of new hyphal outgrowths from parent yeast cells, whereas ICI 153066 and itraconazole had little effect on this phenomenon and ketoconazole and tioconazole had intermediate effects. At the highest concentrations tested (10(-5) M) hyphal development was ultimately arrested by the azole compounds and the fungus grew predominantly in the form of budding yeast cells; however, none of the azole antifungals prevented initial emergence of an apparently normal germ tube. The antifungals only exerted their morphological effects when they were present in the culture medium: removal of the compounds after exposure of C. albicans to them led to reversion to normal growth.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2999296     DOI: 10.1099/00221287-131-10-2581

Source DB:  PubMed          Journal:  J Gen Microbiol        ISSN: 0022-1287


  21 in total

1.  Azole susceptibility and hyphal formation in a cytochrome P-450-deficient mutant of Candida albicans.

Authors:  N D Lees; M C Broughton; D Sanglard; M Bard
Journal:  Antimicrob Agents Chemother       Date:  1990-05       Impact factor: 5.191

Review 2.  Overview of medically important antifungal azole derivatives.

Authors:  R A Fromtling
Journal:  Clin Microbiol Rev       Date:  1988-04       Impact factor: 26.132

Review 3.  Modulation of morphogenesis in Candida albicans by various small molecules.

Authors:  Julie Shareck; Pierre Belhumeur
Journal:  Eukaryot Cell       Date:  2011-06-03

Review 4.  Regulatory circuitry governing fungal development, drug resistance, and disease.

Authors:  Rebecca S Shapiro; Nicole Robbins; Leah E Cowen
Journal:  Microbiol Mol Biol Rev       Date:  2011-06       Impact factor: 11.056

5.  Candida albicans adhesion to and invasion and damage of vaginal epithelial cells: stage-specific inhibition by clotrimazole and bifonazole.

Authors:  Betty Wächtler; Duncan Wilson; Bernhard Hube
Journal:  Antimicrob Agents Chemother       Date:  2011-07-11       Impact factor: 5.191

6.  Effects of fluconazole on the secretome, the wall proteome, and wall integrity of the clinical fungus Candida albicans.

Authors:  Alice G Sorgo; Clemens J Heilmann; Henk L Dekker; Martijn Bekker; Stanley Brul; Chris G de Koster; Leo J de Koning; Frans M Klis
Journal:  Eukaryot Cell       Date:  2011-05-27

7.  Effects of azole antifungal drugs on the transition from yeast cells to hyphae in susceptible and resistant isolates of the pathogenic yeast Candida albicans.

Authors:  K C Ha; T C White
Journal:  Antimicrob Agents Chemother       Date:  1999-04       Impact factor: 5.191

8.  Potentiation of azole antifungals by 2-adamantanamine.

Authors:  Michael D Lafleur; Lingmei Sun; Ida Lister; John Keating; Andre Nantel; Lisa Long; Mahmoud Ghannoum; Jeffrey North; Richard E Lee; Ken Coleman; Thomas Dahl; Kim Lewis
Journal:  Antimicrob Agents Chemother       Date:  2013-05-20       Impact factor: 5.191

9.  Ascorbic acid inhibition of Candida albicans Hsp90-mediated morphogenesis occurs via the transcriptional regulator Upc2.

Authors:  Frédérique Van Hauwenhuyse; Alessandro Fiori; Patrick Van Dijck
Journal:  Eukaryot Cell       Date:  2014-08-01

10.  Cloning and characterization of GNS1: a Saccharomyces cerevisiae gene involved in synthesis of 1,3-beta-glucan in vitro.

Authors:  M el-Sherbeini; J A Clemas
Journal:  J Bacteriol       Date:  1995-06       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.